Latest news
Adding Ibrutinib to Liso-Cel Drives Deep Remissions in R/R CLL/SLL - Targeted OncologyTargeted Oncology · Mon, 10 Aug 2026 16:07:16 GMTWhat Cancers Are Included in the Roundup Lawsuit? - robertkinglawfirm.comrobertkinglawfirm.com · Fri, 07 Aug 2026 16:47:18 GMTHow BTK Inhibitors Like Pirtobrutinib (Jaypirca) Fit Into Chronic Lymphocytic Leukemia Treatment Today - SurvivorNetSurvivorNet · Fri, 07 Aug 2026 07:00:00 GMTDocirbrutinib Yields High Response Rates in MCL and CLL - OncLiveOncLive · Wed, 05 Aug 2026 15:26:11 GMTNurix Phase 3 Trial Tests Bexobrutideg Against CLL Standard of Care - Stock TitanStock Titan · Tue, 04 Aug 2026 05:03:02 GMTNurix Therapeutics Announces First Patient Enrolled in Registrational Phase 3 DAYBreak CLL-306 Trial of Bexobrutideg in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma - finance.yahoo.comfinance.yahoo.com · Tue, 04 Aug 2026 05:00:00 GMTPirtobrutinib Combo Boosts PFS in Previously Treated CLL/SLL - CancerNetworkCancerNetwork · Mon, 03 Aug 2026 14:38:54 GMT